MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
0.6502
-0.0320 (-4.69%)
At close: May 30, 2025, 4:00 PM
0.6583
+0.0081 (1.25%)
After-hours: May 30, 2025, 7:35 PM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $12.72 million as of May 30, 2025. Its market cap has decreased by -37.03% in one year.
Market Cap
12.72M
Enterprise Value
1.65M
1-Year Change
-37.03%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since August 5, 2016, MetaVia's market cap has decreased from $84.50M to $12.72M, a decrease of -84.95%. That is a compound annual growth rate of -19.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 12.70M | -27.43% |
| Dec 31, 2024 | 17.50M | -2.23% |
| Dec 29, 2023 | 17.90M | 280.85% |
| Dec 30, 2022 | 4.70M | -85.49% |
| Dec 31, 2021 | 32.40M | -62.41% |
| Dec 31, 2020 | 86.20M | 1,557.69% |
| Dec 31, 2019 | 5.20M | -55.17% |
| Dec 31, 2018 | 11.60M | -86.27% |
| Dec 29, 2017 | 84.50M | 16.23% |
| Dec 30, 2016 | 72.70M | -13.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |